Lithium may be selected as the mood stabilizer for suicidal bipolar patients and for patients with steroid-induced mania. Carbamazepine may be preferred in patients with comorbid pain syndromes. Gabapentin may be chosen for patients with parkinsonian symptoms and topiramate for those with bulimia.
Ref: - Post, R.M., Frye, M.A., Denicoff, K.D., Speer, A.M., et al. (2001). Preliminary algorithms for treatment-resistant bipolar depression. In: Treatment-resistant mood disorders, (Eds.) Amsterdam, J.D., Hornig, M. & Nierenberg, A.A. pp 350 – 404, Cambridge: Cambridge University Press.
No Pingbacks for this post yet...
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
| << < | > >> | |||||
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 | ||||||
This blog on Clinical Psychopharmacology is maintained by Dr. Shahul Ameen, M.D., Psychiatrist, St. John's Hospital, Kattappana, Idukki, Kerala, India.
Psychopharmacology Tips is a part of PsyPlexus, a portal for mental health professionals.
This blog is only for educational purpose of psychiatrists and other physicians. The information published in this blog is not intended for use as a substitute for consultation to a licensed health professional. Patients and consumers who visit Psychopharmacology Tips should carefully review the information gathered from the site with a professional healthcare provider.